Correction: Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway
Saved in:
| Main Authors: | Liujing Qu, Yu Xin, Jieni Feng, Xiaolei Ren, Zuming Li, Xueru Chen, Guangyan Miao, Jiankun Chen, Chengming Sun, Yue Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1643772/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway
by: Liujing Qu, et al.
Published: (2024-07-01) -
ESPN activates ZEB1-mediated EMT through the PI3K/AKT/mTOR axis to promote osteosarcoma metastasis
by: Ruikai Zhou, et al.
Published: (2025-05-01) -
HMGCL activates autophagy in osteosarcoma through β-HB mediated inhibition of the PI3K/AKT/mTOR signaling pathway
by: Wenda Liu, et al.
Published: (2025-02-01) -
Role and Mechanisms of the mTOR Signalling Pathway in the Synthesis of Milk Components
by: RongNuo Li, et al.
Published: (2025-06-01) -
Targeting mTOR Kinase with Natural Compounds: Potent ATP-Competitive Inhibition Through Enhanced Binding Mechanisms
by: Sulaiman K. Marafie, et al.
Published: (2024-12-01)